Journals / The Anatolian Journal of Cardiology / 2019 / Cilt: 22 - Sayı: 5

Visit-to-visit variability in low-density lipoprotein cholesterol

Pages
278–278
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We read the published article “Visit-to-visit variability in lowdensity lipoprotein cholesterol is associated with adverse events in non-obstructive coronary artery disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We read the published article “Visit-to-visit variability in lowdensity lipoprotein cholesterol is associated with adverse events in non-obstructive coronary artery disease.
📊
Key Findings & Data:We read the published article “Visit-to-visit variability in lowdensity lipoprotein cholesterol is associated with adverse events in non-obstructive coronary artery disease.
💡
Conclusion & Impact:We read the published article “Visit-to-visit variability in lowdensity lipoprotein cholesterol is associated with adverse events in non-obstructive coronary artery disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

We read the published article “Visit-to-visit variability in lowdensity lipoprotein cholesterol is associated with adverse events in non-obstructive coronary artery disease.

🔖

Cite This Article

SOOKAROMDEE, P., WIWANITKIT, V. (2019). Visit-to-visit variability in low-density lipoprotein cholesterol. The Anatolian Journal of Cardiology, Cilt: 22 - Sayı: 5, 278–278. https://ajindex.com/articles/366797

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Gu J, Yin ZF, Pan JA, Zhang JF, Wang CQ. Visit-to-visit variability in low-density lipoprotein cholesterol is associated with adverse events in non-obstructive coronary artery disease. Anatol J Cardiol 2019; 22: 117-24
  2. Matyus SP, Braun PJ, Wolak-Dinsmore J, Jeyarajah EJ, Shalaurova I, Xu Y, et al. NMR measurement of LDL particle number using the Vantera Clinical Analyzer. Clin Biochem 2014; 47: 203-10
  3. Huang YC, Kao JT, Tsai KS. Evaluation of two homogeneous methods for measuring high-density lipoprotein cholesterol. Clin Chem 1997; 43: 1048-55.